The Continence and Catheterization Impact Assessment Survey will take 20 minutes to complete and will provide insight into the quality of life, health, and product needs of people requiring this method of bladder voiding. At the close of the survey a random drawing will be held and one lucky winner voluntarily providing an email address will be awarded a $500.00 gift card.
Your participation is entirely voluntary, and you may stop at any time. There is no compensation for participation. All responses are considered confidential. However, FDA, the Sponsor, and the reviewing Investigational Review Board may be granted direct access to your records for verification of study procedures or data, without violating your confidentiality. If information about the study is published, your identity will remain confidential.
This investigation recognizes that people who use intermittent catheterization as their primary means of bladder management represent a highly variable population with special needs and requirements. The survey investigates various aspects of life and health status, and limitations that individuals may face as a result of bladder voiding with a catheter.
In today’s economy and changing fabric of healthcare, healthcare providers and manufacturers of health care products must gain a comprehensive knowledge of the impact bladder voiding techniques have on an individual’s life. A statistically and scientific rigorous research study regarding the impact of intermittent catheterization will help facilitate this goal.
If you have any questions regarding participation in this survey, please direct them to Thom R. Nichols, Dept. of Global Market Access, Hollister Incorporated, phone 847-918-3464, or email email@example.com.
If you have any questions, complaints or concerns about your rights as a research subject, you may contact Copernicus Group Independent Review Board (IRB) at 1-888-303-2224 (toll free).